Product Detail
5-Dehydroxy (3S)-Atorvastatin-d5
Stable Isotopes
Stock Status: Enquire
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
CAT No. CS-T-101614
Research Use
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
5-Dehydroxy (3S)-Atorvastatin-d5 Product Information
5-Dehydroxy (3S)-Atorvastatin-d5 is listed under Stable Isotopes. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-101614.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
5-Dehydroxy (3S)-Atorvastatin-d5
CAS No.
-
CAT No.
CS-T-101614
Molecular Formula
C33H30D5FN2O4
Molecular Weight
547.67
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
5-Dehydroxy (3S)-Atorvastatin-d5
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"5-Dehydroxy (3S)-Atorvastatin-d5 is an isotopically labelled form of 5-Dehydroxy (3S)-Atorvastatin (D230285), which is an impurity of Atorvastatin (A791750) that is a selective inhibitor of HMG-CoA reductase."
Synonyms
(dS)-2-(4-Fluorophenyl)-d-hydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid-d5;
Application Notes
"5-Dehydroxy (3S)-Atorvastatin-d5 is an isotopically labelled form of 5-Dehydroxy (3S)-Atorvastatin (D230285), which is an impurity of Atorvastatin (A791750) that is a selective inhibitor of HMG-CoA reductase."
References
"Whitfield, L.R., et al.: Eur. J. Drug Metab. Pharmacokinet., 25, 97 (2000);"
